Digital health startups to watch: We spotlight pharma disruptor SmithRx and price transparency platform Turquoise Health on the back of fresh funding.
Fewer breaches, more compromised patient records: Cyber criminals are training their attacks on healthcare’s connected systems, often finding troves of patient data through third-party vendors.
More companies discontinue GLP-1 coverage: Drugmakers reaching sky-high valuations from selling GLP-1s may soon have to decide if it’s worth lowering the price of the meds.
Docs should be kept in the loop on genAI investments: Getting input from physicians on which AI models to deploy and for which clinical purposes will help secure buy-in.
Consumers use CTV for health-related searches: Connected TV watchers looked for fitness and mental health content in early January, per Roku data. That’s a trend healthcare and pharma marketers should jump on.
Buckle up for a gov’t probe, MA marketers: The Senate Finance Committee is ramping up an investigation into Medicare Advantage (MA) marketing practices among some third-party organizations. We don’t see this going away any time soon.
Digital health at CES 2024: AI in healthcare was showcased at CES 2024. We explore how marketers can capitalize on the trend.
Concerning cancer trends for 2024: Cancer rates are down overall, but don’t be misled. Cancer patients are getting younger and there are still overlooked populations getting sicker.
Physicians seek temp positions for better work-life balance: Healthcare employers still face staff shortages and rising labor costs. Physicians want better compensation and flexible work schedules. It’s time for both sides to talk.
Digital health startups to watch: We spotlight multispecialty care group Harbor Health and autism therapy company Forta on the back of fresh funding
Amazon Pharmacy and One Medical grow closer: We explore why Amazon wants its pharmacists more involved with patient care.
Employers demand lower drug costs: Tyson Foods is the latest large US employer to switch its drug benefits plan to an independent pharmacy benefit manager. 2024 could be a watershed year for the US prescription drug market.
Patients generally trust their local health system: They feel much differently about hospitals outside their communities. Here’s how healthcare marketers can use this information to their advantage.
Making the case for heart health: Heart disease is the leading cause of death in the US and it’s getting more costly for employers and health plans. But getting employees to sign on will take some effort.
Home internet use is rising for Medicare beneficiaries: But it’s still limited by socioeconomic factors like race, education, and income status. Here’s what providers and marketers should know about this growing audience.
General Catalyst will buy Summa Health: The VC firm plans to try out digital solutions with the Ohio-based health system. It could flop like Haven—or transform some aspects of the US healthcare system.
Medicare Advantage plans face a challenging year ahead: How might the various headwinds in front of MA insurers affect their businesses in 2024?
You are what you eat: As the food-as-medicine movement gains momentum, success depends on understanding consumers’ daily diets and the choices they make. A YouGov survey should pique marketers’ interest.
On today's podcast episode, our contestants compete in The Great Behind the Numbers Take Off, 2024 health trends edition, where they will try and cook up the most interesting predictions for the coming year. They'll discuss why healthcare is going to be a hyper-partisan issue in the 2024 US election campaigns; how that will affect how people think about and deal with their own healthcare going forward; and why the coming year will create unprecedented challenges for patients when it comes to affording care and treatment, leading them to explore other options for accessing and paying for care. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.
Move over, Mother Nature: In the $1.8T global wellness market, consumers are more attracted to products that boast clinically proven vs. natural ingredients. Here’s what marketers need to know.